TARA-002 For The Treatment Of Patients With Non-Muscle Invasive ... a Complete Response [CR] of 100% [4 out of 4 patients] at 6 months and then 80% [4 out of 5] patients at any time.

B reast cancer is not a single disease but multiple ones, each carrying varying degrees of risk for endangering women’s ...

The Food and Drug Administration (FDA) has approved Tryngolza™ (olezarsen) as an adjunct to diet to reduce triglycerides in adults with familial chylomicronemia syndrome (FCS).

Singer and Christmas music icon Noddy Holder has given an update on his cancer prognosis after doctors told him he could have ...